Our results, by demonstrating the epigenetic-associated silencing of cancer-related genes (ZNF793 and RPRM), provide a molecular mechanism to explain the increased risk of IM progressing to the intestinal type of gastric cancer. The gene discussed is ZNF793; the disease is cancer.